posted fourth-quarter earnings Tuesday that were slightly above Wall Street estimates.
The pharmaceutical products company said it earned 2 cents a share for the quarter, significantly better than the 11-cent-a-share loss posted in the year-ago period. Six analysts polled by
First Call/Thomson Financial
were expecting the company to earn a penny in the quarter.
Shares of COR lost $1.19, or 2.8%, to $40.88 in recent